English

TAURIGA SCIENCES, INC.

EDGAR

TAUG Quarterly report (10-Q) · filed 2022-02-16

100 filing records in this dataset, filed from 2001-11-13 to 2022-02-16. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

103 thousand USD

2022 Q3 · USD

Exact inputs and evidence

Revenue: 102580 USD Source

Operating margin

-1,305.54%

2022 Q3 · %

Exact inputs and evidence

Operating Income: -1339223 USD Source
Revenue: 102580 USD Source

Operating cash flow

-262 thousand USD

2022 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -1443682 USD Source
Operating Cash Flow: -1181183 USD Source

Free cash flow

-262 thousand USD

2022 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -1443682 USD Source
Operating Cash Flow: -1181183 USD Source
Capital Expenditure: 1945 USD Source
Capital Expenditure: 1945 USD Source

Cash and cash equivalents: 6.8 thousand USD 2021-12-31 Source
Exact value

6799 USD
Long-term debt including current maturities: Not available
Shares outstanding: 300 million shares 2021-12-31 Source
Exact value

299908214 shares

Reported share-count change

31.95% · 72.6 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

227291853 shares · 2020-12-31· Source
299908214 shares · 2021-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

313 thousand USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Revenue: 285319 USD · 2020-04-01 – 2021-03-31 Source
Revenue: 215113 USD · 2020-04-01 – 2020-12-31 Source
Revenue: 33367 USD · 2021-04-01 – 2021-06-30 Source
Revenue: 107346 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 102580 USD · 2021-10-01 – 2021-12-31 Source

Net income

-6.12 million USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Net income: -3626446 USD · 2020-04-01 – 2021-03-31 Source
Net income: -1614449 USD · 2020-04-01 – 2020-12-31 Source
Net income: -832364 USD · 2021-04-01 – 2021-06-30 Source
Net income: -1736280 USD · 2021-07-01 – 2021-09-30 Source
Net income: -1542273 USD · 2021-10-01 – 2021-12-31 Source

Operating cash flow

-2.67 million USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Operating cash flow: -2554578 USD · 2020-04-01 – 2021-03-31 Source
Operating cash flow: -1325217 USD · 2020-04-01 – 2020-12-31 Source
Operating cash flow: -758688 USD · 2021-04-01 – 2021-06-30 Source
Operating cash flow: -1181183 USD · 2021-04-01 – 2021-09-30 Source
Operating cash flow: -758688 USD · 2021-04-01 – 2021-06-30 Source
Operating cash flow: -1443682 USD · 2021-04-01 – 2021-12-31 Source
Operating cash flow: -1181183 USD · 2021-04-01 – 2021-09-30 Source

Capital expenditure

13.9 thousand USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Capital expenditure: 16094 USD · 2020-04-01 – 2021-03-31 Source
Capital expenditure: 4138 USD · 2020-04-01 – 2020-12-31 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-06-30 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-09-30 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-06-30 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-12-31 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-09-30 Source

Free cash flow

-2.69 million USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Operating cash flow: -2554578 USD · 2020-04-01 – 2021-03-31 Source
Operating cash flow: -1325217 USD · 2020-04-01 – 2020-12-31 Source
Operating cash flow: -758688 USD · 2021-04-01 – 2021-06-30 Source
Operating cash flow: -1181183 USD · 2021-04-01 – 2021-09-30 Source
Operating cash flow: -758688 USD · 2021-04-01 – 2021-06-30 Source
Operating cash flow: -1443682 USD · 2021-04-01 – 2021-12-31 Source
Operating cash flow: -1181183 USD · 2021-04-01 – 2021-09-30 Source
Capital expenditure: 16094 USD · 2020-04-01 – 2021-03-31 Source
Capital expenditure: 4138 USD · 2020-04-01 – 2020-12-31 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-06-30 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-09-30 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-06-30 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-12-31 Source
Capital expenditure: 1945 USD · 2021-04-01 – 2021-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-02-16.

Financial data available through: 2021-03-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2021-03-31
Operating income: 11 of 11 periods available· newest 2021-03-31
Net income: 11 of 11 periods available· newest 2021-03-31
Operating cash flow: 11 of 11 periods available· newest 2021-03-31
Capital expenditure: 6 of 11 periods available· newest 2021-03-31
Total assets: 5 of 11 periods available· newest 2021-03-31
Total liabilities: 4 of 11 periods available· newest 2021-03-31
Current assets: 5 of 11 periods available· newest 2021-03-31
Current liabilities: 5 of 11 periods available· newest 2021-03-31
Cash and cash equivalents: 5 of 11 periods available· newest 2021-03-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2021-03-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+21.7%

Prior period

USD 234,389

2019-04-01 – 2020-03-31
Current period

USD 285,319

2020-04-01 – 2021-03-31

Exact inputs and evidence

285319 − 234389 = 50930 USD

234389 USD · 2019-04-01 – 2020-03-31
Inspect prior input Prior source
285319 USD · 2020-04-01 – 2021-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Year-over-year change in Revenue: 50930 USD Concept: fundies:Revenue Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 285319 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315222004768/form10-q.htm#1054186 Filing: 000149315222004768 Input fundies:Revenue: 234389 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#365375 Filing: 000149315221019862
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 593,156

Prior period

−USD 3.03 million

2019-04-01 – 2020-03-31
Current period

−USD 3.63 million

2020-04-01 – 2021-03-31

Exact inputs and evidence

-3626446 − -3033290 = -593156 USD

-3033290 USD · 2019-04-01 – 2020-03-31
Inspect prior input Prior source
-3626446 USD · 2020-04-01 – 2021-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Year-over-year change in Net income: -593156 USD Concept: fundies:NetIncome Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3626446 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#343078 Filing: 000149315221019862 Input fundies:NetIncome: -3033290 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#344615 Filing: 000149315221019862
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.04 million

Prior period

−USD 1.51 million

2019-04-01 – 2020-03-31
Current period

−USD 2.55 million

2020-04-01 – 2021-03-31

Exact inputs and evidence

-2554578 − -1510562 = -1044016 USD

-1510562 USD · 2019-04-01 – 2020-03-31
Inspect prior input Prior source
-2554578 USD · 2020-04-01 – 2021-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Year-over-year change in Operating cash flow: -1044016 USD Concept: fundies:OperatingCashFlow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2554578 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#314172 Filing: 000149315221019862 Input fundies:OperatingCashFlow: -1510562 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#314357 Filing: 000149315221019862
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+516.2%

Prior period

USD 2,612

2019-04-01 – 2020-03-31
Current period

USD 16,094

2020-04-01 – 2021-03-31

Exact inputs and evidence

16094 − 2612 = 13482 USD

2612 USD · 2019-04-01 – 2020-03-31
Inspect prior input Prior source
16094 USD · 2020-04-01 – 2021-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Year-over-year change in Capital expenditure: 13482 USD Concept: fundies:CapitalExpenditure Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 16094 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#493210 Filing: 000149315221019862 Input fundies:CapitalExpenditure: 2612 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#493392 Filing: 000149315221019862
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2020-04-01 – 2021-03-31

Revenue USD 285,319 100% of revenue
Cost of revenue USD 162,627 57% of revenue
Operating expenses USD 3.51 million 1,231% of revenue
Operating income −USD 3.39 million −1,188% of revenue
Tax, interest and other Derived USD 236,972 83% of revenue
Net income −USD 3.63 million −1,271% of revenue

Cash

Operating cash flow −USD 2.55 million −895% of revenue
Capital expenditure USD 16,094 5.6% of revenue
Free cash flow Derived −USD 2.57 million −901% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 4,248% of revenue.
2018 Operating loss: operating costs were 159,642% of revenue.
2019 Operating loss: operating costs were 1,996% of revenue.
2020 Operating loss: operating costs were 970% of revenue.
2021 Operating loss: operating costs were 1,288% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2014-04-01 – 2015-03-31	96161	4085135 Derived	-3988974	1099982 Derived	-5088956	Unavailable	Source 2014-04-01 – 2015-03-31: 96161 USD Inspect Revenue Open source 2014-04-01 – 2015-03-31: -3988974 USD Inspect Operating Income Open source 2014-04-01 – 2015-03-31: -5088956 USD Inspect Net Income Open source 2014-04-01 – 2015-03-31: -1844519 USD Inspect Operating Cash Flow Open source
2018 2017-04-01 – 2018-03-31	1188	1896545 Derived	-1895357	-1859230 Derived	-36127	-545423 Derived	Source 2017-04-01 – 2018-03-31: 1188 USD Inspect Revenue Open source 2017-04-01 – 2018-03-31: -1895357 USD Inspect Operating Income Open source 2017-04-01 – 2018-03-31: -36127 USD Inspect Net Income Open source 2017-04-01 – 2018-03-31: -542314 USD Inspect Operating Cash Flow Open source 2017-04-01 – 2018-03-31: 3109 USD Inspect Capital Expenditure Open source
2019 2018-04-01 – 2019-03-31	57134	1140196 Derived	-1083062	14377 Derived	-1097439	-340975 Derived	Source 2018-04-01 – 2019-03-31: 57134 USD Inspect Revenue Open source 2018-04-01 – 2019-03-31: -1083062 USD Inspect Operating Income Open source 2018-04-01 – 2019-03-31: -1097439 USD Inspect Net Income Open source 2018-04-01 – 2019-03-31: -328585 USD Inspect Operating Cash Flow Open source 2018-04-01 – 2019-03-31: 12390 USD Inspect Capital Expenditure Open source
2020 2019-04-01 – 2020-03-31	234389	2273399 Derived	-2039010	994280 Derived	-3033290	-1513174 Derived	Source 2019-04-01 – 2020-03-31: 234389 USD Inspect Revenue Open source 2019-04-01 – 2020-03-31: -2039010 USD Inspect Operating Income Open source 2019-04-01 – 2020-03-31: -3033290 USD Inspect Net Income Open source 2019-04-01 – 2020-03-31: -1510562 USD Inspect Operating Cash Flow Open source 2019-04-01 – 2020-03-31: 2612 USD Inspect Capital Expenditure Open source
2021 2020-04-01 – 2021-03-31	285319	3674793 Derived	-3389474	236972 Derived	-3626446	-2570672 Derived	Source 2020-04-01 – 2021-03-31: 285319 USD Inspect Revenue Open source 2020-04-01 – 2021-03-31: -3389474 USD Inspect Operating Income Open source 2020-04-01 – 2021-03-31: -3626446 USD Inspect Net Income Open source 2020-04-01 – 2021-03-31: -2554578 USD Inspect Operating Cash Flow Open source 2020-04-01 – 2021-03-31: 16094 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 285.3K 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-03-31	Revenue	96161	Revenue: 96161 Open source
20182018-03-31	Revenue	1188	Revenue: 1188 Open source
20192019-03-31	Revenue	57134	Revenue: 57134 Open source
20202020-03-31	Revenue	234389	Revenue: 234389 Open source
20212021-03-31	Revenue	285319	Revenue: 285319 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

21.7% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-03-31	Year over year	No prior comparable period	Revenue: 96161 Open source
20182018-03-31	Year over year	No prior comparable period	Revenue: 1188 Open source
20192019-03-31	Year over year	4,709.3%	Revenue: 57134 Open source Revenue: 1188 Open source
20202020-03-31	Year over year	310.2%	Revenue: 234389 Open source Revenue: 57134 Open source
20212021-03-31	Year over year	21.7%	Revenue: 285319 Open source Revenue: 234389 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,188% 2021

Net margin -1,271% 2021

Free cash flow margin -901% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-03-31	Operating margin	-4,148.2%	Operating Income: -3988974 Open source Revenue: 96161 Open source
20182018-03-31	Operating margin	-159,541.8%	Operating Income: -1895357 Open source Revenue: 1188 Open source
20192019-03-31	Operating margin	-1,895.7%	Operating Income: -1083062 Open source Revenue: 57134 Open source
20202020-03-31	Operating margin	-869.9%	Operating Income: -2039010 Open source Revenue: 234389 Open source
20212021-03-31	Operating margin	-1,188%	Operating Income: -3389474 Open source Revenue: 285319 Open source
20152015-03-31	Net margin	-5,292.1%	Net Income: -5088956 Open source Revenue: 96161 Open source
20182018-03-31	Net margin	-3,041%	Net Income: -36127 Open source Revenue: 1188 Open source
20192019-03-31	Net margin	-1,920.8%	Net Income: -1097439 Open source Revenue: 57134 Open source
20202020-03-31	Net margin	-1,294.1%	Net Income: -3033290 Open source Revenue: 234389 Open source
20212021-03-31	Net margin	-1,271%	Net Income: -3626446 Open source Revenue: 285319 Open source
20152015-03-31	Free cash flow margin	Not reported	Revenue: 96161 Open source Operating Cash Flow: -1844519 Open source
20182018-03-31	Free cash flow margin	-45,911%	Revenue: 1188 Open source Operating Cash Flow: -542314 Open source Capital Expenditure: 3109 Open source
20192019-03-31	Free cash flow margin	-596.8%	Revenue: 57134 Open source Operating Cash Flow: -328585 Open source Capital Expenditure: 12390 Open source
20202020-03-31	Free cash flow margin	-645.6%	Revenue: 234389 Open source Operating Cash Flow: -1510562 Open source Capital Expenditure: 2612 Open source
20212021-03-31	Free cash flow margin	-901%	Revenue: 285319 Open source Operating Cash Flow: -2554578 Open source Capital Expenditure: 16094 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.6M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-03-31	Operating cash flow	-1844519	Operating Cash Flow: -1844519 Open source
20182018-03-31	Operating cash flow	-542314	Operating Cash Flow: -542314 Open source
20192019-03-31	Operating cash flow	-328585	Operating Cash Flow: -328585 Open source
20202020-03-31	Operating cash flow	-1510562	Operating Cash Flow: -1510562 Open source
20212021-03-31	Operating cash flow	-2554578	Operating Cash Flow: -2554578 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.6M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-03-31	Free cash flow	Unavailable	Operating Cash Flow: -1844519 Open source
20182018-03-31	Free cash flow	-545423	Operating Cash Flow: -542314 Open source Capital Expenditure: 3109 Open source
20192019-03-31	Free cash flow	-340975	Operating Cash Flow: -328585 Open source Capital Expenditure: 12390 Open source
20202020-03-31	Free cash flow	-1513174	Operating Cash Flow: -1510562 Open source Capital Expenditure: 2612 Open source
20212021-03-31	Free cash flow	-2570672	Operating Cash Flow: -2554578 Open source Capital Expenditure: 16094 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

48.9% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-03-31	Liabilities / assets	Not reported	Total Assets: 358641 Open source
20182018-03-31	Liabilities / assets	57.1%	Total Liabilities: 393587 Open source Total Assets: 688838 Open source
20192019-03-31	Liabilities / assets	47.6%	Total Liabilities: 457380 Open source Total Assets: 960826 Open source
20202020-03-31	Liabilities / assets	147.9%	Total Liabilities: 951659 Open source Total Assets: 643462 Open source
20212021-03-31	Liabilities / assets	48.9%	Total Liabilities: 1217456 Open source Total Assets: 2488703 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.05× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-03-31	Current assets / current liabilities	0.2×	Current Assets: 333355 Open source Current Liabilities: 1678713 Open source
20182018-03-31	Current assets / current liabilities	2.15×	Current Assets: 686347 Open source Current Liabilities: 318587 Open source
20192019-03-31	Current assets / current liabilities	2.07×	Current Assets: 947816 Open source Current Liabilities: 457380 Open source
20202020-03-31	Current assets / current liabilities	0.64×	Current Assets: 607894 Open source Current Liabilities: 942726 Open source
20212021-03-31	Current assets / current liabilities	2.05×	Current Assets: 2396567 Open source Current Liabilities: 1167356 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2011-12-12 – 2012-12-31	−USD 12.8 million Exact value Exact value: -12802804 USD 2011-12-12 – 2012-12-31: -12802804 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2012-12-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -12802804 USD Concept: fundies:NetIncome Period: 2011-12-12 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2011-12-12&unit=USD&dimensions= Input fundies:NetIncome: -12802804 USD (2011-12-12 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000135448813000754/nvnc-20121231.xml#30125 Filing: 000135448813000754 The citation records this snapshot. The page link may show a newer release later.	−USD 3.25 million Exact value Exact value: -3253172 USD 2011-12-12 – 2012-12-31: -3253172 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2012-12-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -3253172 USD Concept: fundies:OperatingCashFlow Period: 2011-12-12 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2011-12-12&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3253172 USD (2011-12-12 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000135448813000754/nvnc-20121231.xml#56919 Filing: 000135448813000754 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2012-04-01 – 2013-03-31	−USD 11.15 million Exact value Exact value: -11146507 USD 2012-04-01 – 2013-03-31: -11146507 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2013-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -11146507 USD Concept: fundies:NetIncome Period: 2012-04-01 to 2013-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2013-03-31&surface=latest&period_type=duration&start=2012-04-01&unit=USD&dimensions= Input fundies:NetIncome: -11146507 USD (2012-04-01 to 2013-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315215000553/taug-20141231.xml#125803 Filing: 000149315215000553 The citation records this snapshot. The page link may show a newer release later.	−USD 2.65 million Exact value Exact value: -2647490 USD 2012-04-01 – 2013-03-31: -2647490 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2013-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -2647490 USD Concept: fundies:OperatingCashFlow Period: 2012-04-01 to 2013-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2013-03-31&surface=latest&period_type=duration&start=2012-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2647490 USD (2012-04-01 to 2013-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315214002162/taug-20140331.xml#501507 Filing: 000149315214002162 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-04-01 – 2014-03-31	−USD 12.17 million Exact value Exact value: -12168772 USD 2013-04-01 – 2014-03-31: -12168772 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2014-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -12168772 USD Concept: fundies:NetIncome Period: 2013-04-01 to 2014-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2014-03-31&surface=latest&period_type=duration&start=2013-04-01&unit=USD&dimensions= Input fundies:NetIncome: -12168772 USD (2013-04-01 to 2014-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315216010145/taug-20150331.xml#141595 Filing: 000149315216010145 The citation records this snapshot. The page link may show a newer release later.	−USD 1.92 million Exact value Exact value: -1919415 USD 2013-04-01 – 2014-03-31: -1919415 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2014-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -1919415 USD Concept: fundies:OperatingCashFlow Period: 2013-04-01 to 2014-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2014-03-31&surface=latest&period_type=duration&start=2013-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1919415 USD (2013-04-01 to 2014-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315216010145/taug-20150331.xml#810956 Filing: 000149315216010145 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-04-01 – 2015-03-31	−USD 5.09 million Exact value Exact value: -5088956 USD 2014-04-01 – 2015-03-31: -5088956 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2015-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -5088956 USD Concept: fundies:NetIncome Period: 2014-04-01 to 2015-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2015-03-31&surface=latest&period_type=duration&start=2014-04-01&unit=USD&dimensions= Input fundies:NetIncome: -5088956 USD (2014-04-01 to 2015-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315216014031/taug-20160331.xml#410200 Filing: 000149315216014031 The citation records this snapshot. The page link may show a newer release later.	−USD 1.84 million Exact value Exact value: -1844519 USD 2014-04-01 – 2015-03-31: -1844519 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2015-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -1844519 USD Concept: fundies:OperatingCashFlow Period: 2014-04-01 to 2015-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2015-03-31&surface=latest&period_type=duration&start=2014-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1844519 USD (2014-04-01 to 2015-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315216014031/taug-20160331.xml#801566 Filing: 000149315216014031 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-04-01 – 2016-03-31	−USD 2.57 million Exact value Exact value: -2569153 USD 2015-04-01 – 2016-03-31: -2569153 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2016-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -2569153 USD Concept: fundies:NetIncome Period: 2015-04-01 to 2016-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2016-03-31&surface=latest&period_type=duration&start=2015-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2569153 USD (2015-04-01 to 2016-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315217007575/taug-20170331.xml#438679 Filing: 000149315217007575 The citation records this snapshot. The page link may show a newer release later.	−USD 395,536 Exact value Exact value: -395536 USD 2015-04-01 – 2016-03-31: -395536 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2016-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -395536 USD Concept: fundies:OperatingCashFlow Period: 2015-04-01 to 2016-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2016-03-31&surface=latest&period_type=duration&start=2015-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -395536 USD (2015-04-01 to 2016-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315217007575/taug-20170331.xml#711872 Filing: 000149315217007575 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2016-04-01 – 2017-03-31	−USD 2.18 million Exact value Exact value: -2175521 USD 2016-04-01 – 2017-03-31: -2175521 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2017-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -2175521 USD Concept: fundies:NetIncome Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2175521 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315218009295/taug-20180331.xml#357674 Filing: 000149315218009295 The citation records this snapshot. The page link may show a newer release later.	−USD 651,129 Exact value Exact value: -651129 USD 2016-04-01 – 2017-03-31: -651129 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2017-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -651129 USD Concept: fundies:OperatingCashFlow Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -651129 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315218009295/taug-20180331.xml#372710 Filing: 000149315218009295 The citation records this snapshot. The page link may show a newer release later.	USD 1,081 Exact value Exact value: 1081 USD 2016-04-01 – 2017-03-31: 1081 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TAURIGA SCIENCES, INC. · 2017-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Capital Expenditure: 1081 USD Concept: fundies:CapitalExpenditure Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ACapitalExpenditure&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1081 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315218009295/taug-20180331.xml#358290 Filing: 000149315218009295 The citation records this snapshot. The page link may show a newer release later.	−USD 652,210 Calculation and evidence -651129 − 1081 USD Exact free cash flow: -652210 USD 2016-04-01 – 2017-03-31: -651129 USD · Inspect Operating Cash Flow · Source 2016-04-01 – 2017-03-31: 1081 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TAURIGA SCIENCES, INC. · 2017-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Free cash flow: -652210 USD Concept: free-cash-flow Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -651129 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315218009295/taug-20180331.xml#372710 Filing: 000149315218009295 Input fundies:CapitalExpenditure: 1081 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315218009295/taug-20180331.xml#358290 Filing: 000149315218009295 The citation records this snapshot. The page link may show a newer release later.
2018 2017-04-01 – 2018-03-31	−USD 36,127 Exact value Exact value: -36127 USD 2017-04-01 – 2018-03-31: -36127 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2018-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -36127 USD Concept: fundies:NetIncome Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:NetIncome: -36127 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315219009783/taug-20190331.xml#942190 Filing: 000149315219009783 The citation records this snapshot. The page link may show a newer release later.	−USD 542,314 Exact value Exact value: -542314 USD 2017-04-01 – 2018-03-31: -542314 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2018-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -542314 USD Concept: fundies:OperatingCashFlow Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -542314 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315219009783/taug-20190331.xml#312777 Filing: 000149315219009783 The citation records this snapshot. The page link may show a newer release later.	USD 3,109 Exact value Exact value: 3109 USD 2017-04-01 – 2018-03-31: 3109 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TAURIGA SCIENCES, INC. · 2018-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Capital Expenditure: 3109 USD Concept: fundies:CapitalExpenditure Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ACapitalExpenditure&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3109 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315219009783/taug-20190331.xml#303395 Filing: 000149315219009783 The citation records this snapshot. The page link may show a newer release later.	−USD 545,423 Calculation and evidence -542314 − 3109 USD Exact free cash flow: -545423 USD 2017-04-01 – 2018-03-31: -542314 USD · Inspect Operating Cash Flow · Source 2017-04-01 – 2018-03-31: 3109 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TAURIGA SCIENCES, INC. · 2018-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Free cash flow: -545423 USD Concept: free-cash-flow Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -542314 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315219009783/taug-20190331.xml#312777 Filing: 000149315219009783 Input fundies:CapitalExpenditure: 3109 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315219009783/taug-20190331.xml#303395 Filing: 000149315219009783 The citation records this snapshot. The page link may show a newer release later.
2019 2018-04-01 – 2019-03-31	−USD 1.1 million Exact value Exact value: -1097439 USD 2018-04-01 – 2019-03-31: -1097439 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2019-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -1097439 USD Concept: fundies:NetIncome Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1097439 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315220012174/taug-20200331.xml#347653 Filing: 000149315220012174 The citation records this snapshot. The page link may show a newer release later.	−USD 328,585 Exact value Exact value: -328585 USD 2018-04-01 – 2019-03-31: -328585 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2019-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -328585 USD Concept: fundies:OperatingCashFlow Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -328585 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315220012174/taug-20200331.xml#317417 Filing: 000149315220012174 The citation records this snapshot. The page link may show a newer release later.	USD 12,390 Exact value Exact value: 12390 USD 2018-04-01 – 2019-03-31: 12390 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TAURIGA SCIENCES, INC. · 2019-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Capital Expenditure: 12390 USD Concept: fundies:CapitalExpenditure Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ACapitalExpenditure&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12390 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315220012174/taug-20200331.xml#316940 Filing: 000149315220012174 The citation records this snapshot. The page link may show a newer release later.	−USD 340,975 Calculation and evidence -328585 − 12390 USD Exact free cash flow: -340975 USD 2018-04-01 – 2019-03-31: -328585 USD · Inspect Operating Cash Flow · Source 2018-04-01 – 2019-03-31: 12390 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TAURIGA SCIENCES, INC. · 2019-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Free cash flow: -340975 USD Concept: free-cash-flow Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -328585 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315220012174/taug-20200331.xml#317417 Filing: 000149315220012174 Input fundies:CapitalExpenditure: 12390 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315220012174/taug-20200331.xml#316940 Filing: 000149315220012174 The citation records this snapshot. The page link may show a newer release later.
2020 2019-04-01 – 2020-03-31	−USD 3.03 million Exact value Exact value: -3033290 USD 2019-04-01 – 2020-03-31: -3033290 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2020-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -3033290 USD Concept: fundies:NetIncome Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:NetIncome: -3033290 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#344615 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.	−USD 1.51 million Exact value Exact value: -1510562 USD 2019-04-01 – 2020-03-31: -1510562 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2020-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -1510562 USD Concept: fundies:OperatingCashFlow Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1510562 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#314357 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.	USD 2,612 Exact value Exact value: 2612 USD 2019-04-01 – 2020-03-31: 2612 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TAURIGA SCIENCES, INC. · 2020-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Capital Expenditure: 2612 USD Concept: fundies:CapitalExpenditure Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ACapitalExpenditure&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2612 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#493392 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.	−USD 1.51 million Calculation and evidence -1510562 − 2612 USD Exact free cash flow: -1513174 USD 2019-04-01 – 2020-03-31: -1510562 USD · Inspect Operating Cash Flow · Source 2019-04-01 – 2020-03-31: 2612 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TAURIGA SCIENCES, INC. · 2020-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Free cash flow: -1513174 USD Concept: free-cash-flow Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1510562 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#314357 Filing: 000149315221019862 Input fundies:CapitalExpenditure: 2612 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#493392 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.
2021 2020-04-01 – 2021-03-31	−USD 3.63 million Exact value Exact value: -3626446 USD 2020-04-01 – 2021-03-31: -3626446 USD Inspect Net Income Open source Share or cite Citation for Net Income · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Net Income: -3626446 USD Concept: fundies:NetIncome Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ANetIncome&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:NetIncome: -3626446 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#343078 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.	−USD 2.55 million Exact value Exact value: -2554578 USD 2020-04-01 – 2021-03-31: -2554578 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Operating Cash Flow: -2554578 USD Concept: fundies:OperatingCashFlow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3AOperatingCashFlow&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2554578 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#314172 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.	USD 16,094 Exact value Exact value: 16094 USD 2020-04-01 – 2021-03-31: 16094 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Capital Expenditure: 16094 USD Concept: fundies:CapitalExpenditure Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790/explain?concept=fundies%3ACapitalExpenditure&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16094 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#493210 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.	−USD 2.57 million Calculation and evidence -2554578 − 16094 USD Exact free cash flow: -2570672 USD 2020-04-01 – 2021-03-31: -2554578 USD · Inspect Operating Cash Flow · Source 2020-04-01 – 2021-03-31: 16094 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TAURIGA SCIENCES, INC. · 2021-03-31 TAURIGA SCIENCES, INC. (edgar:1142790) Free cash flow: -2570672 USD Concept: free-cash-flow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T21:59:15Z Snapshot: 0c606f3c2da84538b1aaf0e4933f9f386473f66bff0ec2c6fae6a2ea56046cd1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142790?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2554578 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#314172 Filing: 000149315221019862 Input fundies:CapitalExpenditure: 16094 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142790/000149315221019862/taug-20210331.xml#493210 Filing: 000149315221019862 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

100 filings · 2,778 latest values · 2,778 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001142790, 1142790, TAUG, edgar:1142790

Also known as ATLANTIC WINE AGENCIES INC, ATLANTICWINE AGENCIES INC, IMMUNOVATIVE, INC., Immunovative, Inc., NEW ENGLAND ACQUISITIONS INC, Novo Energies Corp, TAURIGA SCIENCES, INC., TAURIGA SCIENCES, INC.

TAURIGA SCIENCES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2020-04-01 – 2021-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation